Cancer is not just a major health issue for people but also a growing development challenge with severe consequences on national well-being and government health budgets. According to the World Health Organization’s International Agency for Research on Cancer, the total annual economic cost of cancer in 2010 was estimated at US $1.16 trillion. This number is expected to have continued to increase as more people develop cancer each year — globally, in 2018, the number of cancer cases exceeded 18 million, with 9.6 million deaths. By 2030, these annual figures are expected to rise to 24 million cases, with 13 million deaths.
Many low and middle income countries are unable to provide sufficient cancer diagnosis and treatment services and must send patients abroad for care, which is expensive and can be a burden on patients and their families. Establishing national cancer care services, including radiotherapy facilities and nuclear medicine units, is a complex undertaking that requires careful planning to set up the highly specialized infrastructure, equipment and training, as well as to mobilize funds.
The IAEA has a long history of supporting countries in using nuclear technology for health. In the area of cancer, it has been transferring technology and building human and institutional capacities for cancer diagnosis and treatment using radiation technology. The IAEA, through its technical cooperation programme, has trained over 2000 health professionals and provided more than €172 million since 2011 to assist countries in developing national cancer care services. In 2019 alone, it supported more than 125 cancer-related projects worldwide.
“Our goal is to work with our Member States, particularly from low and middle income countries, to build and strengthen their capacity in cancer control so that a greater number of patients can be treated safely and effectively,” said Dazhu Yang, IAEA Deputy Director General and Head of the Department of Technical Cooperation.
The IAEA’s support in this area includes specialized training to build human resources and expert advice at all stages of the process, as well as the tools, materials and equipment needed for an operational facility to be set up and be able to provide services.
The impact of this support can be seen in countries such as Sri Lanka, which has been collaborating with the IAEA for more than 40 years to develop the country’s cancer care services. In the last eight years, for example, this collaboration has led to enhanced nuclear medicine imaging capabilities, with highly trained specialists to provide diagnostic services in Sri Lanka.
In central Sri Lanka, a fully equipped nuclear medicine unit has been set up in the city of Kandy to complement a similar facility in Galle, a city in the southern part of the country. A new facility is also being set up in the north, around Jaffna. In October 2019, Sri Lanka hosted an IAEA imPACT Review mission, where experts assessed the country’s progress and assisted in defining plans for its future developments in cancer control.
Our goal is to work with our Member States, particularly from low and middle income countries, to build and strengthen their capacity in cancer control so that a greater number of patients can be treated safely and effectively.